BackgroundAssumptions about survival of HIV-infected children in Africa without antiretroviral therapy need to be updated to inform ongoing UNAIDS modelling of paediatric HIV epidemics among children. Improved estimates of infant survival by timing of HIV-infection (perinatally or postnatally) are thus needed.Methodology/Principal FindingsA pooled analysis was conducted of individual data of all available intervention cohorts and randomized trials on prevention of HIV mother-to-child transmission in Africa. Studies were right-censored at the time of infant antiretroviral initiation. Overall mortality rate per 1000 child-years of follow-up was calculated by selected maternal and infant characteristics. The Kaplan-Meier method was used to est...
Introduction Population-based HIV-free survival at 18–24 months of age among HIV-exposed infants in...
BACKGROUND: Few prospective studies have measured survival rates among human immunodeficiency virus ...
AB Background: Based on clinical trial results, the WHO recommends infant HIV testing at age 4-6 wee...
BACKGROUND: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
BACKGROUND: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Assumptions about survival of HIV-infected children in Africa without antiretroviral therapy need to...
Background: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Background Previously, HIV epidemic models have used a double Weibull curve to represent high initia...
Background Previously, HIV epidemic models have used a double Weibull curve to represent high initia...
ABSTRACT Background: Pediatric HIV is a leading cause of morbidity and mortality worldwide. The subs...
Objective: To assess mortality and clinical outcomes in children treated with antiretroviral therapy...
Background: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Background:Mortality among human immunodeficiency virus-1 (HIV-1) infected children initiated on ant...
Objective: Estimated numbers of children living with HIV determine programmatic and treatment needs....
BACKGROUND: Despite substantial improvements in accessibility of Anti-Retroviral Treatment (ART), de...
Introduction Population-based HIV-free survival at 18–24 months of age among HIV-exposed infants in...
BACKGROUND: Few prospective studies have measured survival rates among human immunodeficiency virus ...
AB Background: Based on clinical trial results, the WHO recommends infant HIV testing at age 4-6 wee...
BACKGROUND: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
BACKGROUND: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Assumptions about survival of HIV-infected children in Africa without antiretroviral therapy need to...
Background: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Background Previously, HIV epidemic models have used a double Weibull curve to represent high initia...
Background Previously, HIV epidemic models have used a double Weibull curve to represent high initia...
ABSTRACT Background: Pediatric HIV is a leading cause of morbidity and mortality worldwide. The subs...
Objective: To assess mortality and clinical outcomes in children treated with antiretroviral therapy...
Background: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Background:Mortality among human immunodeficiency virus-1 (HIV-1) infected children initiated on ant...
Objective: Estimated numbers of children living with HIV determine programmatic and treatment needs....
BACKGROUND: Despite substantial improvements in accessibility of Anti-Retroviral Treatment (ART), de...
Introduction Population-based HIV-free survival at 18–24 months of age among HIV-exposed infants in...
BACKGROUND: Few prospective studies have measured survival rates among human immunodeficiency virus ...
AB Background: Based on clinical trial results, the WHO recommends infant HIV testing at age 4-6 wee...